

Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|15|1|45-56
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.15, Iss.1, 2009-01, pp. : 45-56
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Pharmaceutical Strategies for Stabilizing Drug Nanocrystals
Current Pharmaceutical Design, Vol. 24, Iss. 21, 2018-06 ,pp. :


NAD+, Sirtuins, and Cardiovascular Disease
Current Pharmaceutical Design, Vol. 15, Iss. 1, 2009-01 ,pp. :


A Review on SIRtuins in Diabetes
Current Pharmaceutical Design, Vol. 23, Iss. 16, 2017-06 ,pp. :


Structure and Evolution of Human Sirtuins
Current Drug Targets, Vol. 14, Iss. 6, 2013-06 ,pp. :